Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Gene</td><td class="align_center">Coef</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">ATP1A3</td><td class="align_center">0.130955704</td></tr><tr><td class="align_left">GRIN2D</td><td class="align_center">0.236142949</td></tr><tr><td class="align_left">PLA2G2D</td><td class="align_center">−0.373104088</td></tr><tr><td class="align_left">GALNT10</td><td class="align_center">0.448763921</td></tr><tr><td class="align_left">LAMP3</td><td class="align_center">−0.162535052</td></tr><tr><td class="align_left">GALNT6</td><td class="align_center">−0.069757800</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div><i>Note</i>. Coef, coefficient.<br/></div></td></tr></table>

<div>The risk coefficient value of each core gene.</div>

Mediators of Inflammation

tab1

Table 1

Table 1: Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer 